Pneumococcal vaccination coverage and willingness in mainland China
Objectives To estimate the coverage and willingness of pneumococcal vaccination and further explore the influencing factors of vaccination willingness among people in mainland China. Methods Literature searches were conducted independently by two researchers in English‐ and Chinese‐language database...
Saved in:
Published in | Tropical medicine & international health Vol. 27; no. 10; pp. 864 - 872 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Oxford
Blackwell Publishing Ltd
01.10.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Objectives
To estimate the coverage and willingness of pneumococcal vaccination and further explore the influencing factors of vaccination willingness among people in mainland China.
Methods
Literature searches were conducted independently by two researchers in English‐ and Chinese‐language databases from database inception to 6 October 2021. A random‐effects meta‐analysis model was used to derive summary vaccination coverage and willingness. Predefined subgroup analysis and meta‐regression were performed to explore the sources of heterogeneity.
Results
A total of 97 studies were included in this meta‐analysis. The summary vaccination coverage in 76 included studies was 21.7% (95% confidence interval [CI]: 17.2%–26.5%). Subgroup analysis shows that the summary coverage was 29.0% (95% CI, 20.4%–39.1%) among the permanent residents and 20.7% (95% CI, 12.4%–35.9%) among the floating residents. The eastern and central regions presented higher coverage than the western region. Notable differences were observed between the various study populations. A total of 27 studies provided an estimation of vaccination willingness, with a summary willingness of 51.2% (95% CI, 40.4%–61.9%). In subgroup analysis, the summary willingness was 57.9% (95% CI, 48.3%–67.2%) in urban areas and 52.3% (95% CI, 40.8%–63.8%) in rural areas. Parents with children and people with a history of pneumonia were more willing to be vaccinated than the elderly. Recommendations by family members and physicians, previous pneumococcal and influenza vaccination, perceived vaccination effectiveness and severity of disease and a history of pneumonia contributed to vaccination willingness.
Conclusions
Compared to global estimates and other countries, pneumococcal vaccination coverage and willingness are at a lower level in mainland China. Recommendations for vaccination by family members and doctors, a history of vaccination and the perception of pneumonia and vaccination are associated with greater willingness to be vaccinated. |
---|---|
AbstractList | Objectives
To estimate the coverage and willingness of pneumococcal vaccination and further explore the influencing factors of vaccination willingness among people in mainland China.
Methods
Literature searches were conducted independently by two researchers in English‐ and Chinese‐language databases from database inception to 6 October 2021. A random‐effects meta‐analysis model was used to derive summary vaccination coverage and willingness. Predefined subgroup analysis and meta‐regression were performed to explore the sources of heterogeneity.
Results
A total of 97 studies were included in this meta‐analysis. The summary vaccination coverage in 76 included studies was 21.7% (95% confidence interval [CI]: 17.2%–26.5%). Subgroup analysis shows that the summary coverage was 29.0% (95% CI, 20.4%–39.1%) among the permanent residents and 20.7% (95% CI, 12.4%–35.9%) among the floating residents. The eastern and central regions presented higher coverage than the western region. Notable differences were observed between the various study populations. A total of 27 studies provided an estimation of vaccination willingness, with a summary willingness of 51.2% (95% CI, 40.4%–61.9%). In subgroup analysis, the summary willingness was 57.9% (95% CI, 48.3%–67.2%) in urban areas and 52.3% (95% CI, 40.8%–63.8%) in rural areas. Parents with children and people with a history of pneumonia were more willing to be vaccinated than the elderly. Recommendations by family members and physicians, previous pneumococcal and influenza vaccination, perceived vaccination effectiveness and severity of disease and a history of pneumonia contributed to vaccination willingness.
Conclusions
Compared to global estimates and other countries, pneumococcal vaccination coverage and willingness are at a lower level in mainland China. Recommendations for vaccination by family members and doctors, a history of vaccination and the perception of pneumonia and vaccination are associated with greater willingness to be vaccinated. To estimate the coverage and willingness of pneumococcal vaccination and further explore the influencing factors of vaccination willingness among people in mainland China.OBJECTIVESTo estimate the coverage and willingness of pneumococcal vaccination and further explore the influencing factors of vaccination willingness among people in mainland China.Literature searches were conducted independently by two researchers in English- and Chinese-language databases from database inception to 6 October 2021. A random-effects meta-analysis model was used to derive summary vaccination coverage and willingness. Predefined subgroup analysis and meta-regression were performed to explore the sources of heterogeneity.METHODSLiterature searches were conducted independently by two researchers in English- and Chinese-language databases from database inception to 6 October 2021. A random-effects meta-analysis model was used to derive summary vaccination coverage and willingness. Predefined subgroup analysis and meta-regression were performed to explore the sources of heterogeneity.A total of 97 studies were included in this meta-analysis. The summary vaccination coverage in 76 included studies was 21.7% (95% confidence interval [CI]: 17.2%-26.5%). Subgroup analysis shows that the summary coverage was 29.0% (95% CI, 20.4%-39.1%) among the permanent residents and 20.7% (95% CI, 12.4%-35.9%) among the floating residents. The eastern and central regions presented higher coverage than the western region. Notable differences were observed between the various study populations. A total of 27 studies provided an estimation of vaccination willingness, with a summary willingness of 51.2% (95% CI, 40.4%-61.9%). In subgroup analysis, the summary willingness was 57.9% (95% CI, 48.3%-67.2%) in urban areas and 52.3% (95% CI, 40.8%-63.8%) in rural areas. Parents with children and people with a history of pneumonia were more willing to be vaccinated than the elderly. Recommendations by family members and physicians, previous pneumococcal and influenza vaccination, perceived vaccination effectiveness and severity of disease and a history of pneumonia contributed to vaccination willingness.RESULTSA total of 97 studies were included in this meta-analysis. The summary vaccination coverage in 76 included studies was 21.7% (95% confidence interval [CI]: 17.2%-26.5%). Subgroup analysis shows that the summary coverage was 29.0% (95% CI, 20.4%-39.1%) among the permanent residents and 20.7% (95% CI, 12.4%-35.9%) among the floating residents. The eastern and central regions presented higher coverage than the western region. Notable differences were observed between the various study populations. A total of 27 studies provided an estimation of vaccination willingness, with a summary willingness of 51.2% (95% CI, 40.4%-61.9%). In subgroup analysis, the summary willingness was 57.9% (95% CI, 48.3%-67.2%) in urban areas and 52.3% (95% CI, 40.8%-63.8%) in rural areas. Parents with children and people with a history of pneumonia were more willing to be vaccinated than the elderly. Recommendations by family members and physicians, previous pneumococcal and influenza vaccination, perceived vaccination effectiveness and severity of disease and a history of pneumonia contributed to vaccination willingness.Compared to global estimates and other countries, pneumococcal vaccination coverage and willingness are at a lower level in mainland China. Recommendations for vaccination by family members and doctors, a history of vaccination and the perception of pneumonia and vaccination are associated with greater willingness to be vaccinated.CONCLUSIONSCompared to global estimates and other countries, pneumococcal vaccination coverage and willingness are at a lower level in mainland China. Recommendations for vaccination by family members and doctors, a history of vaccination and the perception of pneumonia and vaccination are associated with greater willingness to be vaccinated. ObjectivesTo estimate the coverage and willingness of pneumococcal vaccination and further explore the influencing factors of vaccination willingness among people in mainland China.MethodsLiterature searches were conducted independently by two researchers in English‐ and Chinese‐language databases from database inception to 6 October 2021. A random‐effects meta‐analysis model was used to derive summary vaccination coverage and willingness. Predefined subgroup analysis and meta‐regression were performed to explore the sources of heterogeneity.ResultsA total of 97 studies were included in this meta‐analysis. The summary vaccination coverage in 76 included studies was 21.7% (95% confidence interval [CI]: 17.2%–26.5%). Subgroup analysis shows that the summary coverage was 29.0% (95% CI, 20.4%–39.1%) among the permanent residents and 20.7% (95% CI, 12.4%–35.9%) among the floating residents. The eastern and central regions presented higher coverage than the western region. Notable differences were observed between the various study populations. A total of 27 studies provided an estimation of vaccination willingness, with a summary willingness of 51.2% (95% CI, 40.4%–61.9%). In subgroup analysis, the summary willingness was 57.9% (95% CI, 48.3%–67.2%) in urban areas and 52.3% (95% CI, 40.8%–63.8%) in rural areas. Parents with children and people with a history of pneumonia were more willing to be vaccinated than the elderly. Recommendations by family members and physicians, previous pneumococcal and influenza vaccination, perceived vaccination effectiveness and severity of disease and a history of pneumonia contributed to vaccination willingness.ConclusionsCompared to global estimates and other countries, pneumococcal vaccination coverage and willingness are at a lower level in mainland China. Recommendations for vaccination by family members and doctors, a history of vaccination and the perception of pneumonia and vaccination are associated with greater willingness to be vaccinated. |
Author | Shao, Weihao Chen, Xiaorui Zheng, Caifang Zhang, Weidong Wang, Gaili Zhang, Bowen |
Author_xml | – sequence: 1 givenname: Weihao surname: Shao fullname: Shao, Weihao organization: Zhengzhou University – sequence: 2 givenname: Xiaorui surname: Chen fullname: Chen, Xiaorui organization: Zhengzhou University – sequence: 3 givenname: Caifang surname: Zheng fullname: Zheng, Caifang organization: Zhengzhou University – sequence: 4 givenname: Gaili surname: Wang fullname: Wang, Gaili organization: Zhengzhou University – sequence: 5 givenname: Bowen surname: Zhang fullname: Zhang, Bowen organization: Zhengzhou University – sequence: 6 givenname: Weidong orcidid: 0000-0002-0314-7820 surname: Zhang fullname: Zhang, Weidong email: imooni@zzu.edu.cn organization: Zhengzhou University |
BookMark | eNp1kElPwzAQhS1UJNrCgX8QiQsc0nrJekQRSyUQHMrZcoZJcZXYxU6L-u9xl1MFvow1-t7MmzciA2MNEnLN6ISFN-07PWGioOUZGTKRpbFgaTbY_2nMeZ5dkJH3S0ppkqTZkFTvBtedBQug2mijALRRvbYmArtBpxYYKfMZ_ei21WZh0PtIm6hT2rS7fvUV8Ety3qjW49WxjsnH48O8eo5f3p5m1f1LDMFIGTdYZlBAQ_OyDPszmiaAQGsONQiRFwViinUBLKkbZBB6irG85mnKQLBGiDG5PcxdOfu9Rt_LTnvANjhBu_aS55QKlguaBfTmBF3atTPBXaA45TzkwQM1PVDgrPcOGwm631_fO6VbyajchSpDqHIfalDcnShWTnfKbf9kj9NDeLj9H5Tz19lB8QuWg4fN |
CitedBy_id | crossref_primary_10_1080_21645515_2024_2440959 crossref_primary_10_1080_21645515_2024_2440955 crossref_primary_10_1080_21645515_2025_2454744 crossref_primary_10_1186_s40249_023_01150_8 crossref_primary_10_1016_j_ijmedinf_2022_104941 crossref_primary_10_1371_journal_pone_0314098 crossref_primary_10_26599_AGR_2024_9340027 |
Cites_doi | 10.1016/S2214-109X(18)30247-X 10.1080/21645515.2020.1870396 10.1080/21645515.2016.1230577 10.1371/journal.pone.0169368 10.1097/INF.0000000000001288 10.1016/j.vaccine.2021.04.029 10.1186/s12879-016-1820-8 10.1186/s12889-018-6080-7 10.1016/j.vaccine.2014.06.047 10.1016/j.vaccine.2016.02.032 10.15585/mmwr.mm6740a4 10.15585/mmwr.mm6846a5 10.1002/sim.1186 10.3390/vaccines9030212 10.15585/mmwr.ss7003a1 10.1016/S1473-3099(15)70044-7 10.1371/journal.pone.0170550 10.1016/j.vaccine.2016.11.003 10.1016/j.vaccine.2018.08.023 10.3390/vaccines8030426 10.1080/21645515.2018.1470726 10.1016/j.diabet.2019.06.003 10.1016/S0140-6736(11)61878-3 10.1371/journal.pmed.1000270 10.1016/j.ijid.2011.11.004 10.15585/mmwr.mm6504a4 10.1136/bmj.n71 10.4161/21645515.2014.972155 10.1371/journal.pone.0166736 10.1136/bmj.315.7121.1533 10.1186/1471-2458-14-232 10.1371/journal.pone.0177985 10.1073/pnas.2004933118 10.1186/s12889-015-1998-5 10.1371/journal.pmed.1003326 10.1080/14760584.2021.1954910 10.1080/21645515.2020.1814653 10.1080/21645515.2020.1776545 10.1016/j.ijsu.2014.07.013 |
ContentType | Journal Article |
Copyright | 2022 John Wiley & Sons Ltd. 2022 John Wiley & Sons Ltd |
Copyright_xml | – notice: 2022 John Wiley & Sons Ltd. – notice: 2022 John Wiley & Sons Ltd |
DBID | AAYXX CITATION 7T2 7U9 C1K H94 K9. M7N 7X8 |
DOI | 10.1111/tmi.13809 |
DatabaseName | CrossRef Health and Safety Science Abstracts (Full archive) Virology and AIDS Abstracts Environmental Sciences and Pollution Management AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Algology Mycology and Protozoology Abstracts (Microbiology C) MEDLINE - Academic |
DatabaseTitle | CrossRef AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Health & Safety Science Abstracts Virology and AIDS Abstracts Algology Mycology and Protozoology Abstracts (Microbiology C) Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic AIDS and Cancer Research Abstracts |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Public Health |
EISSN | 1365-3156 |
EndPage | 872 |
ExternalDocumentID | 10_1111_tmi_13809 TMI13809 |
Genre | reviewArticle |
GeographicLocations | China |
GeographicLocations_xml | – name: China |
GroupedDBID | --- .3N .GA .GJ .Y3 05W 0R~ 10A 123 1OC 24P 29Q 2WC 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5HH 5LA 5VS 66C 6PF 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANLZ AAONW AASGY AAVGM AAWTL AAXRX AAYCA AAZKR ABCQN ABCUV ABEML ABJNI ABLJU ABOCM ABPPZ ABPVW ABQWH ABXGK ACAHQ ACCFJ ACCZN ACGFO ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXME ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEGXH AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHMBA AIACR AIAGR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AZBYB AZVAB BAFTC BAWUL BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM DU5 E3Z EBS EJD ESX EX3 F00 F01 F04 F5P FIJ FUBAC G-S G.N GODZA GX1 H.X HF~ HGLYW HZI HZ~ IHE IPNFZ IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D PQQKQ Q.N Q11 QB0 R.K ROL RX1 SUPJJ TEORI TR2 UB1 V8K W8V W99 WBKPD WHWMO WIH WIJ WIK WIN WOHZO WOW WQJ WRC WVDHM WXI WXSBR XG1 YFH YUY ZGI ZZTAW ~IA ~KM ~WT AAYXX AEYWJ AGHNM AGYGG CITATION 7T2 7U9 AAMMB AEFGJ AGXDD AIDQK AIDYY C1K H94 K9. M7N 7X8 |
ID | FETCH-LOGICAL-c3659-fe96c8cf07990006054cec0b2cbc33788ee5eb8c14bfe1cc33a117b2551c31f33 |
IEDL.DBID | DR2 |
ISSN | 1360-2276 1365-3156 |
IngestDate | Thu Jul 10 22:31:03 EDT 2025 Sat Jul 19 13:10:50 EDT 2025 Tue Jul 01 04:13:49 EDT 2025 Thu Apr 24 22:55:13 EDT 2025 Wed Jan 22 16:21:46 EST 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3659-fe96c8cf07990006054cec0b2cbc33788ee5eb8c14bfe1cc33a117b2551c31f33 |
Notes | Good Health and Wellbeing, Reduced Inequalities, Sustainable Cities and Communities Sustainable Development Goals ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
ORCID | 0000-0002-0314-7820 |
OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/tmi.13809 |
PQID | 2720221362 |
PQPubID | 33016 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_2700317306 proquest_journals_2720221362 crossref_citationtrail_10_1111_tmi_13809 crossref_primary_10_1111_tmi_13809 wiley_primary_10_1111_tmi_13809_TMI13809 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | October 2022 2022-10-00 20221001 |
PublicationDateYYYYMMDD | 2022-10-01 |
PublicationDate_xml | – month: 10 year: 2022 text: October 2022 |
PublicationDecade | 2020 |
PublicationPlace | Oxford |
PublicationPlace_xml | – name: Oxford |
PublicationTitle | Tropical medicine & international health |
PublicationYear | 2022 |
Publisher | Blackwell Publishing Ltd |
Publisher_xml | – name: Blackwell Publishing Ltd |
References | 2012; 61 2021; 9 2015; 15 1997; 315 2010; 59 2021; 20 2000; 49 2020; 41 2011 2020; 17 2012; 16 2018; 67 2016; 16 2016; 35 2016; 34 2021; 70 2016; 11 2020; 8 2018; 6 2018; 18 2003; 327 2021 2019; 68 2021; 17 2021; 39 2017; 13 2017; 12 2021; 118 2016; 65 2014; 14 2020; 46 2021; 372 2008; 83 2012; 379 2012; 87 2012; 21 2014; 12 2010; 7 2018; 14 2018; 36 2014; 32 2014; 10 e_1_2_8_28_1 Nuorti JP (e_1_2_8_18_1) 2010; 59 e_1_2_8_24_1 e_1_2_8_47_1 e_1_2_8_26_1 e_1_2_8_49_1 e_1_2_8_3_1 e_1_2_8_5_1 (e_1_2_8_4_1) 2012; 87 e_1_2_8_7_1 e_1_2_8_9_1 e_1_2_8_20_1 e_1_2_8_43_1 e_1_2_8_45_1 e_1_2_8_41_1 e_1_2_8_17_1 Centers for Disease Control and Prevention (CDC) (e_1_2_8_19_1) 2012; 61 e_1_2_8_13_1 e_1_2_8_36_1 e_1_2_8_15_1 e_1_2_8_38_1 Lu L (e_1_2_8_23_1) 2012; 21 e_1_2_8_32_1 e_1_2_8_11_1 e_1_2_8_34_1 e_1_2_8_51_1 e_1_2_8_30_1 e_1_2_8_29_1 e_1_2_8_25_1 e_1_2_8_46_1 Chinese Preventive Medicine Association; Vaccine and Immunology Branch of the Chinese Preventive Medicine Association (e_1_2_8_21_1) 2020; 41 e_1_2_8_27_1 e_1_2_8_48_1 Advisory Committee on Immunization Practices (e_1_2_8_22_1) 2000; 49 e_1_2_8_2_1 McLaughlin JM (e_1_2_8_8_1) 2018; 67 e_1_2_8_6_1 e_1_2_8_42_1 e_1_2_8_44_1 e_1_2_8_40_1 e_1_2_8_39_1 WHO (e_1_2_8_16_1) 2008; 83 e_1_2_8_14_1 e_1_2_8_35_1 e_1_2_8_37_1 e_1_2_8_10_1 e_1_2_8_31_1 e_1_2_8_12_1 e_1_2_8_33_1 e_1_2_8_50_1 |
References_xml | – year: 2011 – volume: 67 start-page: 1123 year: 2018 end-page: 8 article-title: Vaccination coverage among children aged 19–35 months ‐ United States, 2017 publication-title: MMWR Morb Mortal Wkly Rep – volume: 15 year: 2015 article-title: Does introducing an immunization package of services for migrant children improve the coverage, service quality and understanding? An evidence from an intervention study among 1548 migrant children in eastern China publication-title: BMC Public Health – volume: 6 start-page: 744 year: 2018 end-page: 57 article-title: Burden of and type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000–15 publication-title: Lancet Glob Health – volume: 12 year: 2017 article-title: Effectiveness of the 23‐valent pneumococcal polysaccharide vaccine (ppv23) against pneumococcal disease in the elderly: systematic review and meta‐analysis publication-title: PLoS One – volume: 9 year: 2021 article-title: Heightened willingness toward pneumococcal vaccination in the elderly population in Shenzhen, China: a cross‐sectional study during the COVID‐19 pandemic publication-title: Vaccines – year: 2021 – volume: 41 start-page: 1945 year: 2020 end-page: 79 article-title: Expert consensus on immunoprophylaxis of pneumococcal disease publication-title: Chin J Epidemiol – volume: 16 start-page: 136 year: 2012 end-page: 45 article-title: Gender inequities, relationship power, and childhood immunization uptake in Nigeria: a population‐based cross‐sectional study publication-title: Int J Infect Dis – volume: 17 start-page: 527 year: 2021 end-page: 36 article-title: Facilitators and barriers to completing recommended doses of pneumococcal vaccination among community‐living individuals aged ≥65 years in Hong Kong ‐ a population‐based study publication-title: Hum Vaccin Immunother – volume: 59 start-page: 1 year: 2010 end-page: 18 article-title: Prevention of pneumococcal disease among infants and children ‐ use of 13‐valent pneumococcal conjugate vaccine and 23‐valent pneumococcal polysaccharide vaccine ‐ recommendations of the Advisory Committee on Immunization Practices (ACIP) publication-title: MMWR Recomm Rep – volume: 118 year: 2021 article-title: Health and economic impact of the pneumococcal conjugate vaccine in hindering antimicrobial resistance in China publication-title: Proc Natl Acad Sci U S A – volume: 34 start-page: 6158 year: 2016 end-page: 65 article-title: Cost‐effectiveness of a 23‐valent pneumococcal polysaccharide vaccine immunization programme for the elderly in Shanghai, China publication-title: Vaccine – volume: 327 start-page: 557 year: 2003 end-page: 60 article-title: Measuring inconsistency in meta‐analyses publication-title: BMJ – volume: 15 start-page: 535 year: 2015 end-page: 43 article-title: Effect of the 13‐valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study publication-title: Lancet Infect Dis – volume: 379 start-page: 843 year: 2012 end-page: 52 article-title: Urbanisation and health in China publication-title: Lancet – volume: 61 start-page: 816 year: 2012 end-page: 9 article-title: Use of 13‐Valent pneumococcal conjugate vaccine and 23‐valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP) publication-title: Morb Mortal Wkly Rep – volume: 36 start-page: 5886 year: 2018 end-page: 90 article-title: The impact on vaccination coverage following introduction of a routine pneumococcal vaccination programme for the elderly in Japan publication-title: Vaccine – volume: 12 start-page: 1495 year: 2014 end-page: 9 article-title: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies publication-title: Int J Surg – volume: 65 start-page: 86 year: 2016 end-page: 7 article-title: Advisory committee on immunization practices recommended immunization schedules for persons aged 0 through 18 years‐‐United States, 2016 publication-title: MMWR Morb Mortal Wkly Rep – volume: 35 start-page: e353 year: 2016 end-page: 61 article-title: Cost‐effectiveness and health benefits of pediatric 23‐valent pneumococcal polysaccharide vaccine, 7‐valent pneumococcal conjugate vaccine and forecasting 13‐valent pneumococcal conjugate vaccine in China publication-title: Pediatr Infect Dis J – volume: 8 year: 2020 article-title: Pneumococcal vaccination for children in Asian countries: a systematic review of economic evaluation studies publication-title: Vaccines – volume: 68 start-page: 1069 year: 2019 end-page: 75 article-title: Use of 13‐valent pneumococcal conjugate vaccine and 23‐valent pneumococcal polysaccharide vaccine among adults aged ≥65 years: updated recommendations of the advisory committee on immunization practices publication-title: MMWR Morb Mortal Wkly Rep – volume: 14 start-page: 2303 year: 2018 end-page: 9 article-title: Current status and future directions of invasive pneumococcal diseases and prophylactic approaches to control them publication-title: Hum Vaccin Immunother – volume: 17 year: 2020 article-title: Effectiveness of the 23‐valent pneumococcal polysaccharide vaccine against vaccine serotype pneumococcal pneumonia in adults: a case‐control test‐negative design study publication-title: PLoS Med – volume: 32 start-page: 4471 year: 2014 end-page: 7 article-title: Determinants of willingness to pay for self‐paid vaccines in China publication-title: Vaccine – volume: 20 start-page: 1147 year: 2021 end-page: 52 article-title: Gap between willingness and behavior in the vaccination against influenza, pneumonia, and herpes zoster among Chinese aged 50‐69 years publication-title: Expert Rev Vaccines – volume: 34 start-page: 2135 year: 2016 end-page: 40 article-title: The free vaccination policy of influenza in Beijing, China: the vaccine coverage and its associated factors publication-title: Vaccine – volume: 12 year: 2017 article-title: Effectiveness of pneumococcal vaccines in preventing pneumonia in adults, a systematic review and meta‐analyses of observational studies publication-title: PLoS One. – volume: 12 year: 2017 article-title: Barriers of influenza vaccination intention and behavior ‐ a systematic review of influenza vaccine hesitancy, 2005 ‐ 2016 publication-title: PLoS One – volume: 70 start-page: 1 year: 2021 end-page: 26 article-title: Surveillance of vaccination coverage among adult populations ‐United States publication-title: MMWR Surveill Summ – volume: 10 start-page: 2994 year: 2014 end-page: 9 article-title: Factors associated with pneumococcal vaccination among an urban elderly population in China publication-title: Hum Vaccin Immunother – volume: 67 start-page: 1498 year: 2018 end-page: 506 article-title: Effectiveness of 13‐valent pneumococcal conjugate vaccine against hospitalization for community‐acquired pneumonia in older US adults: a test‐negative design publication-title: Clin Infect Dis – volume: 83 start-page: 193 year: 2008 end-page: 208 article-title: Meeting of the Immunization Strategic Advisory Group of Experts, November 2007‐conclusions and recommendations publication-title: Wkly Epidemiol Rec – volume: 39 start-page: 3287 year: 2021 end-page: 95 article-title: Vaccination rates and adherence in pneumococcal conjugate vaccination in mature born infants before and after vaccination schedule change ‐ a claims database analysis publication-title: Vaccine – volume: 13 start-page: 190 year: 2017 end-page: 7 article-title: A cross‐sectional vaccination coverage study in preschool children attending nurseries‐kindergartens: implications on economic crisis effect publication-title: Hum Vaccin Immunother – volume: 49 start-page: 1 year: 2000 end-page: 35 article-title: Preventing pneumococcal disease among infants and young children. Recommendations of the advisory committee on immunization practices (ACIP) publication-title: MMWR Recomm Rep – volume: 87 start-page: 129 year: 2012 end-page: 44 article-title: Pneumococcal vaccines WHO position paper‐‐2012 publication-title: Wkly Epidemiol Rec – volume: 17 start-page: 2241 year: 2021 end-page: 8 article-title: Cost‐effectiveness analysis of domestic 13‐valent pneumococcal conjugate vaccine for children under 5 years of age in mainland China publication-title: Hum Vaccin Immunother – volume: 18 year: 2018 article-title: Factors associated with pneumococcal vaccination in elderly people: a cross‐sectional study among elderly club members in Miyakonojo City publication-title: Japan BMC Public Health – volume: 372 year: 2021 article-title: The PRISMA 2020 statement: an updated guideline for reporting systematic reviews publication-title: BMJ – volume: 315 start-page: 1533 year: 1997 end-page: 7 article-title: Meta‐analysis: principles and procedures publication-title: BMJ – volume: 7 year: 2010 article-title: A population‐based evaluation of a publicly funded, school‐based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receipt publication-title: PLoS Med – volume: 14 year: 2014 article-title: Factors associated with non‐utilization of child immunization in Pakistan: evidence from the Demographic and Health Survey 2006‐07 publication-title: BMC Public Health – volume: 17 start-page: 1455 year: 2021 end-page: 62 article-title: Illness representations on pneumonia and pneumococcal vaccination uptake among community‐living Chinese people with high‐risk conditions aged ≥65 years—a population‐based study publication-title: Hum Vaccin Immunother – volume: 11 year: 2016 article-title: Impact and effectiveness of 10 and 13‐valent pneumococcal conjugate vaccines on hospitalization and mortality in children aged less than 5 years in Latin American countries: a systematic review publication-title: PLoS One. – volume: 21 start-page: 1099 year: 2012 end-page: 102 article-title: Advance in 23‐valent pneumococcal polysaccharide vaccine publication-title: Chin J New Drugs – volume: 16 year: 2016 article-title: Influenza and pneumococcal vaccination in Australian adults: a systematic review of coverage and factors associated with uptake publication-title: BMC Infect Dis – volume: 46 start-page: 137 year: 2020 end-page: 43 article-title: Factors associated with pneumococcal vaccination in 2040 people with type 2 diabetes: a cross‐sectional study publication-title: Diabetes Metab – ident: e_1_2_8_2_1 doi: 10.1016/S2214-109X(18)30247-X – ident: e_1_2_8_12_1 doi: 10.1080/21645515.2020.1870396 – ident: e_1_2_8_32_1 doi: 10.1080/21645515.2016.1230577 – volume: 59 start-page: 1 year: 2010 ident: e_1_2_8_18_1 article-title: Prevention of pneumococcal disease among infants and children ‐ use of 13‐valent pneumococcal conjugate vaccine and 23‐valent pneumococcal polysaccharide vaccine ‐ recommendations of the Advisory Committee on Immunization Practices (ACIP) publication-title: MMWR Recomm Rep – ident: e_1_2_8_5_1 doi: 10.1371/journal.pone.0169368 – ident: e_1_2_8_13_1 doi: 10.1097/INF.0000000000001288 – ident: e_1_2_8_33_1 doi: 10.1016/j.vaccine.2021.04.029 – ident: e_1_2_8_35_1 doi: 10.1186/s12879-016-1820-8 – ident: e_1_2_8_47_1 doi: 10.1186/s12889-018-6080-7 – ident: e_1_2_8_40_1 doi: 10.1016/j.vaccine.2014.06.047 – ident: e_1_2_8_39_1 doi: 10.1016/j.vaccine.2016.02.032 – ident: e_1_2_8_31_1 doi: 10.15585/mmwr.mm6740a4 – volume: 83 start-page: 193 year: 2008 ident: e_1_2_8_16_1 article-title: Meeting of the Immunization Strategic Advisory Group of Experts, November 2007‐conclusions and recommendations publication-title: Wkly Epidemiol Rec – ident: e_1_2_8_17_1 doi: 10.15585/mmwr.mm6846a5 – volume: 87 start-page: 129 year: 2012 ident: e_1_2_8_4_1 article-title: Pneumococcal vaccines WHO position paper‐‐2012 publication-title: Wkly Epidemiol Rec – volume: 41 start-page: 1945 year: 2020 ident: e_1_2_8_21_1 article-title: Expert consensus on immunoprophylaxis of pneumococcal disease publication-title: Chin J Epidemiol – ident: e_1_2_8_26_1 doi: 10.1002/sim.1186 – ident: e_1_2_8_49_1 doi: 10.3390/vaccines9030212 – ident: e_1_2_8_34_1 doi: 10.15585/mmwr.ss7003a1 – ident: e_1_2_8_6_1 doi: 10.1016/S1473-3099(15)70044-7 – ident: e_1_2_8_36_1 doi: 10.1371/journal.pone.0170550 – ident: e_1_2_8_14_1 doi: 10.1016/j.vaccine.2016.11.003 – ident: e_1_2_8_29_1 – ident: e_1_2_8_38_1 doi: 10.1016/j.vaccine.2018.08.023 – ident: e_1_2_8_11_1 doi: 10.3390/vaccines8030426 – ident: e_1_2_8_3_1 doi: 10.1080/21645515.2018.1470726 – volume: 49 start-page: 1 year: 2000 ident: e_1_2_8_22_1 article-title: Preventing pneumococcal disease among infants and young children. Recommendations of the advisory committee on immunization practices (ACIP) publication-title: MMWR Recomm Rep – ident: e_1_2_8_48_1 doi: 10.1016/j.diabet.2019.06.003 – ident: e_1_2_8_43_1 doi: 10.1016/S0140-6736(11)61878-3 – volume: 21 start-page: 1099 year: 2012 ident: e_1_2_8_23_1 article-title: Advance in 23‐valent pneumococcal polysaccharide vaccine publication-title: Chin J New Drugs – ident: e_1_2_8_50_1 doi: 10.1371/journal.pmed.1000270 – ident: e_1_2_8_25_1 – ident: e_1_2_8_41_1 doi: 10.1016/j.ijid.2011.11.004 – ident: e_1_2_8_20_1 doi: 10.15585/mmwr.mm6504a4 – ident: e_1_2_8_24_1 doi: 10.1136/bmj.n71 – ident: e_1_2_8_45_1 doi: 10.4161/21645515.2014.972155 – ident: e_1_2_8_10_1 doi: 10.1371/journal.pone.0166736 – ident: e_1_2_8_28_1 doi: 10.1136/bmj.315.7121.1533 – ident: e_1_2_8_42_1 doi: 10.1186/1471-2458-14-232 – ident: e_1_2_8_7_1 doi: 10.1371/journal.pone.0177985 – volume: 61 start-page: 816 year: 2012 ident: e_1_2_8_19_1 article-title: Use of 13‐Valent pneumococcal conjugate vaccine and 23‐valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP) publication-title: Morb Mortal Wkly Rep – ident: e_1_2_8_15_1 doi: 10.1073/pnas.2004933118 – ident: e_1_2_8_44_1 doi: 10.1186/s12889-015-1998-5 – volume: 67 start-page: 1498 year: 2018 ident: e_1_2_8_8_1 article-title: Effectiveness of 13‐valent pneumococcal conjugate vaccine against hospitalization for community‐acquired pneumonia in older US adults: a test‐negative design publication-title: Clin Infect Dis – ident: e_1_2_8_30_1 – ident: e_1_2_8_9_1 doi: 10.1371/journal.pmed.1003326 – ident: e_1_2_8_37_1 doi: 10.1080/14760584.2021.1954910 – ident: e_1_2_8_51_1 doi: 10.1080/21645515.2020.1814653 – ident: e_1_2_8_46_1 doi: 10.1080/21645515.2020.1776545 – ident: e_1_2_8_27_1 doi: 10.1016/j.ijsu.2014.07.013 |
SSID | ssj0004456 |
Score | 2.4163542 |
SecondaryResourceType | review_article |
Snippet | Objectives
To estimate the coverage and willingness of pneumococcal vaccination and further explore the influencing factors of vaccination willingness among... ObjectivesTo estimate the coverage and willingness of pneumococcal vaccination and further explore the influencing factors of vaccination willingness among... To estimate the coverage and willingness of pneumococcal vaccination and further explore the influencing factors of vaccination willingness among people in... |
SourceID | proquest crossref wiley |
SourceType | Aggregation Database Enrichment Source Index Database Publisher |
StartPage | 864 |
SubjectTerms | Confidence intervals coverage Families & family life Heterogeneity Immunization influencing factors Influenza Literature reviews Medical personnel Meta-analysis pneumococcal vaccination Pneumonia Population studies Rural areas Statistical analysis Streptococcus infections Subgroups Urban areas Vaccination |
Title | Pneumococcal vaccination coverage and willingness in mainland China |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Ftmi.13809 https://www.proquest.com/docview/2720221362 https://www.proquest.com/docview/2700317306 |
Volume | 27 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dS8MwED_GHkQQP6bidEoUH3zpaJp-4pMMxxQmIhvsQShNmsLQdeJaBf96L-nHpiiIb21zpddc7nLJXX4HcI5TKjV9jvrtohhs9EENnuBtkjCJhtIOolhFdId37mBs306cSQMuq7MwBT5EveGmNEPba6XgEV-sKHk2m3Yp8_XhPZWrpRyihyV0lG3ryq3YYhqW5bklqpDK4qnf_DoXLR3MVTdVzzP9LXisOCzSS566eca74uMbeOM_f2EbNkv_k1wVA2YHGjJtwdqwjLC3YKPYxyPF8aRd6N2nMp_N0WyiMMlbJJBMC5MIlfyJ1ohEaUzepxrbW9lNMk3JLJqmKmWS6PLcezDuX496A6MsvGAI7MjASGTgCl8kphcEGrHFsYUUJrcEF0wB0EvpSO4LavNEUoHPIko9jqsTKhhNGNuHZjpP5QEQz_NRyTn3mMPt2IsDywuk70SOoIxT7rThohJBKEpUclUc4zmsVifYSaHupDac1aQvBRTHT0SdSo5hqY2LUMWaLQuHgtWG07oZ9UgFR6JUznNFo-wb2jsXWdJC-_0j4Wh4oy8O_056BOuKiSIPsAPN7DWXx-jPZPxED9xPHG3vdg |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1LT9tAEB6hVCqVqrakRaSl7YKoxMWRd_0-9FBBUULiCKEg5Wa867UUQZyqOEXtb-Kv8J86s7YDVFTiwoGbHyP5MTPfjGfH3wDsYEjldijRv31Ug4s5qCVz3M1zRyNQulGa0YpuPPJ7J-7hxJuswFXzL0zFD7EsuJFnGLwmB6eC9C0vL2fTLndCO6pbKgf69yV-sF187e-jdr8IcfB9vNez6pkClnJ8L7JyHfkqVLkdRJEhI_FcpZUthZLKIW51rT0tQ8VdmWuu8FjKeSAx8ebK4TmVPxHwn9EEcWLq3z--IatyXTMrlju-bQkR-DWPEfUNLW_1bvS7SWlvJ8Ymsh28huvmnVQNLWfdRSm76s8_dJFP5aW9gVd1is2-VT6xBiu6aMPzuG4iaMPLqlTJqj-w3sLeUaEXszlGBrRX9itVKGbslSnqb0XAZWmRscupoS-n0MCmBZul04K6QpmZQP4OTh7lkdahVcwLvQEsCELEMSkDx5NuFmSRCCIdeqmnuCO59Dqw2-g8UTXxOs3_OE-aDzBUSmKU0oHtpeiPim3kPqHNxnCSGnAuElpOFwJtT3Rga3kaoYLWf9JCzxckQxCOkO7jLRkr-f9FknHcNxvvHy76GVZ743iYDPujwQd4ISgBMsWqTWiVPxf6I6ZvpfxkvIbB6WNb3F_hXk3F |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1LT9wwEB4hkBBSBXRpxfIopgKJS1ax4zx86KFiu2K77AohkPaWxo4jrdrNItiA4C_xV_qjOnYeQNVKvXDoLY-R4mRmvhnbk28ADjCkUjeS6N8BqoFjDurIDE-zzNMIlFwkqdnRHY6Ck0v-deyPF-Cx_hem5IdoFtyMZ1i8Ng5-lWbPnHw-nXSoF7miqqgc6Ps7nK_dfOp3UbmHjPW-XByfOFVLAUd5gS-cTItARSpzQyEsF4nPlVauZEoqz1Cra-1rGSnKZaapwmsJpaHEvJsqj2Zm9RPxfokHrjB9IrrnT1xVnNtWsdQLXIexMKhojEzZUDPUl8HvKaN9nhfbwNZbg5_1JynrWb53irnsqIff2CL_k2-2DqtVgk0-lx7xFhZ03oLlYVVC0II35UIlKf-_2oDjs1wX0xnGBbRWcpsoFLPWSpSpbkW4JUmekruJJS83gYFMcjJNJrmpCSW2__g7uHyVV3oPi_ks15tAwjBCFJMy9HzJ0zAVLBQ68hNfUU9S6bfhqFZ5rCraddP940dcT79QKbFVShs-NqJXJdfIn4R2aruJK7i5ic1mOmNoeqwN-81tBAqz-5PkelYYGQPgCOgBDskayd8fEl8M-_Zg699F92D5rNuLT_ujwTasmPGUNY87sDi_LvQu5m5z-cH6DIFvr21wvwCMe0xw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pneumococcal+vaccination+coverage+and+willingness+in+mainland+China&rft.jtitle=Tropical+medicine+%26+international+health&rft.au=Shao%2C+Weihao&rft.au=Chen%2C+Xiaorui&rft.au=Zheng%2C+Caifang&rft.au=Wang%2C+Gaili&rft.date=2022-10-01&rft.pub=Blackwell+Publishing+Ltd&rft.issn=1360-2276&rft.eissn=1365-3156&rft.volume=27&rft.issue=10&rft.spage=864&rft.epage=872&rft_id=info:doi/10.1111%2Ftmi.13809&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1360-2276&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1360-2276&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1360-2276&client=summon |